Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-25T16:44:11.399Z Has data issue: false hasContentIssue false

Ethical and Social Challenges in Newborn Screening for Prenatal Alcohol Exposure

Published online by Cambridge University Press:  23 September 2014

Allison Yan
Affiliation:
Institut de recherches cliniques de Montré (IRCM) Montreal, Quebec, Canada
Emily Bell
Affiliation:
Institut de recherches cliniques de Montré (IRCM) Montreal, Quebec, Canada
Eric Racine
Affiliation:
Institut de recherches cliniques de Montré (IRCM) Montreal, Quebec, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Copyright
Copyright © The Canadian Journal of Neurological 2014

References

1. Public Health Agency of Canada. What is fetal alcohol spectrum disorder (FASD)? Public Health Agency of Canada, Ottawa, ON, 2007, Available at: http://www.phac-aspc.gc.ca/hp-ps/dcadea/prog-ini/fasd-etcaf/publications/pdf/factsheet1-fasd-etcafeng.pdf, accessed August 6, 2013.Google Scholar
2. Joya, X, Friguls, B, Ortigosa, S, et al. Determination of maternal-fetal biomarkers of prenatal exposure to ethanol: a review. J Pharm Biomed Anal. 2012;69:20922.CrossRefGoogle ScholarPubMed
3. Canadian Association of Paediatric Health Centres. National screening tool kit for children and youth identified and potentially affected by FASD, Canadian Association of Paediatric Health Centres, Ottawa, ON, 2012, Available at http://ken.caphc.org/xwiki/bin/download/FASDScreeningToolkit/National+Screening+Tool+Kit+for+Children+and+Youth+Identified+and+Potentially+Affected+by+FASD/FASDToolKit-BoundEN.pdf, accessed August 6, 2013.Google Scholar
4. Zizzo, N, Di Pietro, N, Green, C, Reynolds, J, Bell, E, Racine, E. Review and reflections on ethics in screening for biomarkers of prenatal alcohol exposure. Alcohol Clin Exp Res. 2013 Sep;37 (9):14515.CrossRefGoogle ScholarPubMed
5. Dickens, BM. Legal and ethical considerations in meconium testing for fetal exposure to alcohol. J Popul Ther Clin Pharmacol. 2011;18(3):e4714.Google ScholarPubMed
6. Koren, G, Hutson, J, Gareri, J. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Clin Pharmacol Ther. 2008;83(4):6314.CrossRefGoogle ScholarPubMed
7. Zelner, I, Koren, G. Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. Ther Drug Monit. 2009; 31(2):1702.CrossRefGoogle ScholarPubMed